This stability eliminates the need for protective carriers required by other growth factors, making both oral and injectable administration viable
Recent research work investigated nanocapsules fabricated with carboxymethyl chitosan, chitosan hydrochloride, and -lactoglobulin to enhance the stability of roselle anthocyanins
4 The A is to avoid stroke and blood clots, the R is to reduce symptoms through rate or rhythm control, and the E is ongoing evaluation as things change
So what does that mean in like real-world talk
doi: 10.1007/s00383-020-04783-0 42 CalabriaACCharlesLGivlerSDe LeonDD
Potential Limitations Associated with Neurotransmitter-based Treatments While neurotransmitter-based therapeutics may provide a new therapeutic avenue for AD in the future upon further validation, some of its limitations should be addressed prior to determining its efficacy for AD treatment